Hanmi Pharm publishes GRI Standard-based 'CSR Report'
Hanmi Pharm publishes GRI Standard-based 'CSR Report'
  • Lee Kap-soo
  • 승인 2020.05.14 10:55
  • 댓글 0
이 기사를 공유합니다

Hanmi Pharm has published a "2019-20 Corporate Social Responsibility (CSR) report based on Global Reporting Initiative (GRI) Standard, an international standard for sustainability report and posted it on its website (www.hanmi.co.kr), a company spokesman said on May 13.

As the importance of corporate social roles has recently emerged, many companies have been pushing to publish GRI Standard-based sustainable management reports, while Hanmi Pharm was the first Korean pharmaceutical company to publish a CSR report in 2018. Hanmi Pharm then published a total of three consecutive reports until 2019 and 2020.

This year's CSR report of Hanmi Pharm consists of topics such as "R&D Management for New Challenges," "Challenges for Customer Satisfaction Management," "The Value of Respect for Ethical Management," "Human Resources Management," "Healthy and Safe Business Sites," EHS Management, shared growth, and win-win management.

Hanmi Pharm has decided to actively participate in the implementation of SDGs (Sustainable Development Goals) implemented by the UN and the international community, while regularly visualizing its non-financial information with the publication of CSR reports every year and releasing it on its website.

An official of the Korea Standards Association, who conducted a third-party verification of the report, said, "Hanmi Pharm is Korea's leading R&D-focused pharmaceutical company that focuses on creating global new drugs, and it is implementing CSV strategies that pursue corporate values through R&D and create social values based on them."

He added, "We hope that the publication of this report will actively inform stakeholders of the ESG performance of Hanmi Pharm, and take a step forward in achieving global sustainable development goals."

Meanwhile, Lim Jong-ho, executive director of Hanmi Pharm's CSR team, said, "As a pharmaceutical company that fulfills its social responsibilities, the core and goal of sustainable management are new drug development and R&D. We will create a virtuous circle in which innovative results generated by continuous R&D can lead to the realization of social values."


댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
댓글쓰기
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.

  • ABOUT
  • CONTACT US
  • SIGN UP MEMBERSHIP
  • RSS
  • 2-D 678, National Assembly-daero, 36-gil, Yeongdeungpo-gu, Seoul, Korea (Postal code: 07257)
  • URL: www.koreaittimes.com | Editorial Div: 82-2-578- 0434 / 82-10-2442-9446 | North America Dept: 070-7008-0005 | Email: info@koreaittimes.com
  • Publisher and Editor in Chief: Monica Younsoo Chung | Chief Editorial Writer: Hyoung Joong Kim | Editor: Yeon Jin Jung
  • Juvenile Protection Manager: Choul Woong Yeon
  • Masthead: Korea IT Times. Copyright(C) Korea IT Times, All rights reserved.
ND소프트